|
ASCO 2016: Poster Session 366 |
Using blood tests to determine whether it is possible to more accurately determine risk of uveal melanoma. This may have uses in familial, or germline, mutations where particular markers can be associated with increased likelihood of disease occurence.
No comments:
Post a Comment